New hope for 10x’ preliminary injunction after EPO Opposition Division ruling | Patent at issue concerns single-cell spatial ...

Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...

Bank of New York Mellon Corp lowered its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 13.5% in the ...

Shares of 10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) have received a consensus rating of “Hold” from the seventeen analysts that are currently covering the company, Ratings reports. One ...

Single-cell transcriptomics has revolutionized the study of cellular diversity and function by enabling gene expression ...

The pass rate for the final assessment of candidates aspiring to become chartered accountants drastically increased from 52% in December 2023 to 73% in December last year. This, according to the ...

A growing leader in the diagnostics space, Nucleus Genomics expands access to genetic screening and testing beyond what patients may be able to get from their regular healthcare providers.

Outcomes highlighted the value of ultra-targeted messaging, as target users clicked-through nearly 10x ... used microarray testing, which looks at less than 0.1% of DNA sequencing, meaning that ...

Genetic testing can be critical to ensuring the early diagnosis and proper treatment of serious disease for patients of all ages The partnership combines Ubie's AI-driven symptom identification ...

1 School of Computer and Information Engineering, Luoyang Institute of Science and Technology, Luoyang, China 2 State Key Laboratory of Bioelectronics; School of Biological Science & Medical ...

Austin Argentieri, PhD, lead study author and a research associate at the Harvard/MGH Center on Genomics, Vulnerable Populations, and Health Disparities. "This does not mean that diet might not be ...